1-1 of 1
Xiu Zhi Yang, MD
Close
Sort by
Journal Articles

Evaluation of XL999, a Potent Inhibitor of FGFR3, for the Potential Treatment of t(4;14) Positive Multiple Myeloma.

Suzanne Trudel, MD, Xiu Zhi Yang, MD, Zhi Hua Li, MD, Sheng-ben Liang, PhD, Dana T. Aftab, PhD
Journal: Blood
Blood (2007) 110 (11): 2515.
https://doi.org/10.1182/blood.V110.11.2515.2515
Published: 2007